Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1989-06-20
1991-04-09
Lee, Lester L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
A61K 3702
Patent
active
050065106
ABSTRACT:
A particularly preferred peptide has the amino acid sequence ##STR1## and is combined with a carrier effective to promote passage of the peptide through a patient's skin for an antinociceptive composition useful for relieving pain in a patient experiencing burning pain or hyperesthesia. Topical application of the composition has been found dramatically to reduce such pain in most individuals treated for periods of from about 5-24 hours, and continued control of the pain can be had by daily doses.
REFERENCES:
patent: 3981996 (1976-09-01), Leigh
patent: 4091090 (1978-05-01), Tibor
patent: 4395403 (1983-06-01), Bauer et al.
patent: 4496543 (1985-01-01), Bauer et al.
Weber et al., Surgery, vol. 102(6), pp. 974-981.
M. Matucci-Cerinic, M.D. et al., "Somatostatin Treatment of Psoriatic Arthritis", Jan.-Feb. 1988, pp. 56-58, International Journal of Dermatology, vol. 27, No. 1.
Sandostatin.RTM. octreotide acetate/SANDOZ Injection--Product insert, pp. 1-2, Columns 1-4, 1989 Sandoz Pharmaceuticals Corporation.
Lee Lester L.
Maebius Stephen B.
LandOfFree
Method for relieving chronic pain with a somatostatin analog com does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for relieving chronic pain with a somatostatin analog com, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for relieving chronic pain with a somatostatin analog com will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2034519